Atlas Trials

Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPD

Clinical trial NCT02055352 · COMPLETED

Trial details

NCT number
NCT02055352
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease
Start date
2014-05-30
Primary completion
2016-01-26
Enrollment
222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.